Hikma Pharmaceuticals PLC Cash Flow Reinvestment Rate
Hikma Pharmaceuticals PLC cash flow reinvestment rate. Hikma Pharmaceuticals PLC (HIK) has a Cash Flow Reinvestment Rate of 0.42x as of June 2025, reinvesting GBX68.00 Million (capex GBX68.00 Million ) from operating cash flow of GBX161.00 Million. See Hikma Pharmaceuticals PLC (HIK) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hikma Pharmaceuticals PLC (2002–2024)
Cash flow reinvestment rate of Hikma Pharmaceuticals PLC from 2002 to 2024. Historical reinvestment intensity for Hikma Pharmaceuticals PLC across 23 annual periods. Explore HIK operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Hikma Pharmaceuticals PLC Cash Flow Reinvestment Rate by Year (2002–2024)
Hikma Pharmaceuticals PLC cash flow reinvestment rate by year from 2002 to 2024. Year-by-year capital reinvestment analysis for Hikma Pharmaceuticals PLC. For the full cash flow conversion analysis, see Hikma Pharmaceuticals PLC cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | GBX546.00 Million | GBX564.00 Million | GBX165.00 Million | ▲ +17.3% |
| 2023 | 0.83x | GBX502.00 Million | GBX608.00 Million | GBX169.00 Million | ▼ -47.4% |
| 2022 | 1.57x | GBX832.00 Million | GBX530.00 Million | GBX225.00 Million | ▲ +114.5% |
| 2021 | 0.73x | GBX467.00 Million | GBX638.00 Million | GBX229.00 Million | ▲ +49.6% |
| 2020 | 0.49x | GBX227.00 Million | GBX464.00 Million | GBX224.00 Million | ▲ +19.0% |
| 2019 | 0.41x | GBX194.00 Million | GBX472.00 Million | GBX186.00 Million | ▲ +59.2% |
| 2018 | 0.26x | GBX111.00 Million | GBX430.00 Million | GBX107.00 Million | ▼ -0.6% |
| 2017 | 0.26x | GBX115.00 Million | GBX443.00 Million | GBX107.00 Million | ▼ -90.7% |
| 2016 | 2.79x | GBX817.00 Million | GBX293.00 Million | GBX122.00 Million | ▲ +890.8% |
| 2015 | 0.28x | GBX103.00 Million | GBX366.00 Million | GBX82.00 Million | ▲ +6.8% |
| 2014 | 0.26x | GBX112.00 Million | GBX425.00 Million | GBX91.00 Million | ▲ +5.7% |
| 2013 | 0.25x | GBX84.00 Million | GBX337.00 Million | GBX59.00 Million | ▼ -49.7% |
| 2012 | 0.50x | GBX90.19 Million | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX78.00 Million | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX53.20 Million | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX40.38 Million | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX65.52 Million | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX54.99 Million | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX52.44 Million | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX23.98 Million | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX21.33 Million | GBX32.84 Million | GBX21.33 Million | — |
| 2003 | 0.00x | GBX0.00 | GBX18.35 Million | GBX0.00 | — |
| 2002 | 0.00x | GBX0.00 | GBX14.35 Million | GBX0.00 | — |